UK HVC Spoke 003
Trial Details
- Trial statusCompleted
- Study email contactukhvc@imperial.ac.uk
- Chief InvestigatorSheena McCormack
- Project managerAleisha Miller
- SponsorImperial College London
- ISRCTN numberNA
- Phase1
- View clinicaltrials.gov website
A Phase I clinical trial investigating immunisation strategies using DNA, MVA and CN54rgp140 adjuvanted with GLA-AF to maximise antibody responses
Design and Objective
Design: A randomised Phase I, two centre study
Key inclusion criteria
1. Man or woman aged between 18 and 45 years on the day of screening 2. Available for follow-up for the duration of the study (up to ~10 months from enrolment) 3. At low risk of HIV 4. Willing to undergo an HIV test and a genital infection screen if indicated by sexual history 5. Effective contraception 6. Agree to abstain from blood donation